Published in Medicine and Law Weekly, November 14th, 2008
"The acquisition of Avalon is aligned with our core strategy of identifying proprietary biomarkers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.